Council approves PPI strategy for Society
The Royal Pharmaceutical Society is to appoint a staff member to take forward a three-year strategy for public and patient involvement (PPI) in the Society's work.
The appointment was approved at the December
Council
meeting after the
Council had received a report on the results of the Society’s consultation
on developing a PPI strategy (PJ, 1 July, p23).
The Council also agreed to the establishment of a public liaison group.
This would reflect the direction taken by other health professional bodies
and was considered more resource-efficient and more effective than the
original proposal of a steering group plus a public involvement network.
Introducing a report on the consultation, Council member Ray Jobling
said that it had attracted an overwhelmingly favourable response from
a wide range of those consulted, although there had been some concerns
that the strategy might deflect attention from the issue of how the Council
communicates with the profession.
|
The
Pharmaceutical Journal